Bexmarilimab
Bexmarilimab is a monoclonal antibody from Faron Pharmaceuticals Ltd, in registered phase 2 trials for acute myeloid leukaemia, chronic myelomonocytic leukaemia and MDS/MPN overlap neoplasms, myelodysplastic syndromes / neoplasms.
Overview
Bexmarilimab is listed on ClinicalTrials.gov as an intervention in 1 registered phase 2 trial sponsored by Faron Pharmaceuticals Ltd, in acute myeloid leukaemia, chronic myelomonocytic leukaemia and MDS/MPN overlap neoplasms, myelodysplastic syndromes / neoplasms. A monoclonal antibody: the international non-proprietary name stem -mab marks an antibody that binds one target. The registry record does not state the target unless named in the trial entries below. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
A monoclonal antibody: the international non-proprietary name stem -mab marks an antibody that binds one target. The registry record does not state the target unless named in the trial entries below.
1.Bexmarilimab binds its target.
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Landmark trials
Latest papers
topQuery for this drug: (TITLE:"Bexmarilimab" OR ABSTRACT:"Bexmarilimab" OR TITLE:"FP-1305" OR ABSTRACT:"FP-1305") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Bexmarilimab, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentARD103
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia and the tags pipeline, registry-only.
- TreatmentTuspetinib
Shares Chronic myelomonocytic leukaemia and MDS/MPN overlap neoplasms, Myelodysplastic syndromes / neoplasms (MDS) and the tags pipeline, registry-only.
- TreatmentJBI-802
Shares Chronic myelomonocytic leukaemia and MDS/MPN overlap neoplasms and the tags pipeline, registry-only.
- TreatmentSabatolimab
Shares Myelodysplastic syndromes / neoplasms (MDS) and the tags pipeline, registry-only.
- TreatmentSpartalizumab
Shares Myelodysplastic syndromes / neoplasms (MDS) and the tags pipeline, registry-only.
- TrialFirst-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia and the tag pipeline.
- TrialA Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia and the tag pipeline.
- TrialPBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDS
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia and the tag pipeline.